Skip to content

APOTHEEK WOLFS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK WOLFS

BE 0889.535.332
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€112,192
2024 · €120,472-€8,280
Equity
€615,329
2024 · €575,591+€39,738
Cash
€443,089
2024 · €358,069+€85,020
Balance sheet total
€916,811
2024 · €845,942+€70,870

Largest movements

2024 to 2025
Assets
  • Cash +€85,020

    up €85,020 (+23.7%), from €358,069 to €443,089

    mainly Net result for the year (+€112,192) and Other debts (+€44,650)

  • Tangible fixed assets -€21,324

    down €21,324 (-13.1%), from €162,525 to €141,201

    of which Land and buildings: -€17,368

  • Current investments +€12,099

    up €12,099 (+7.8%), from €155,503 to €167,602

Equity and liabilities
  • Other debts +€44,650

    up €44,650 (+23.7%), from €188,029 to €232,679

  • Reserves +€39,738

    up €39,738 (+7.1%), from €556,991 to €596,729

  • Trade debts -€10,810

    down €10,810 (-19.4%), from €55,791 to €44,982

Income statement
  • Gross operating margin -€9,972

    down €9,972 (-4.6%), from €215,577 to €205,605

  • Taxes -€3,975

    down €3,975 (-7.8%), from €50,834 to €46,858

  • Financial charges +€3,212

    up €3,212 (+17.0%), from €18,878 to €22,090

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €120,472
Gross operating margin -€9,972
Depreciation +€255
Other operating charges -€97
Financial income +€772
Financial charges -€3,212
Taxes +€3,975
Result 2025 €112,192
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€171,571
Investment -€14,097
Financing -€72,454
Cash 2024 €358,069
Net result for the year +€112,192
Depreciation +€23,322
Stocks and contracts +€4,838
Receivables within one year +€1,015
Deferred charges and accrued income -€927
Trade debts -€10,810
Tax, wage and social debts -€2,688
Other debts +€44,650
Accrued charges and deferred income -€21
Investment in fixed assets (net) -€1,998
Current investments -€12,099
Contributions, distributions and other -€72,454
Cash 2025 €443,089
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €845,942 €916,811 +€70,870 +8.4%
Fixed assets 21/28 €162,525 €141,201 -€21,324 -13.1%
Tangible fixed assets 22/27 €162,525 €141,201 -€21,324 -13.1%
Land and buildings 22 €128,102 €110,734 -€17,368 -13.6%
Plant, machinery and equipment 23 €28,266 €25,626 -€2,640 -9.3%
Furniture and vehicles 24 €6,157 €4,840 -€1,316 -21.4%
Current assets 29/58 €683,417 €775,611 +€92,194 +13.5%
Stocks and contracts in progress 3 €71,832 €66,994 -€4,838 -6.7%
Stocks 30/36 €71,832 €66,994 -€4,838 -6.7%
Amounts receivable within one year 40/41 €80,108 €79,093 -€1,015 -1.3%
Trade receivables 40 €80,101 €79,088 -€1,012 -1.3%
Other amounts receivable 41 €8 €5 -€3 -37.0%
Current investments 50/53 €155,503 €167,602 +€12,099 +7.8%
Cash at bank and in hand 54/58 €358,069 €443,089 +€85,020 +23.7%
Deferred charges and accrued income 490/1 €17,905 €18,832 +€927 +5.2%
Total equity and liabilities 10/49 €845,942 €916,811 +€70,870 +8.4%
Equity 10/15 €575,591 €615,329 +€39,738 +6.9%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €556,991 €596,729 +€39,738 +7.1%
Distributable reserves 133 €556,991 €596,729 +€39,738 +7.1%
Amounts payable 17/49 €270,350 €301,482 +€31,131 +11.5%
Amounts payable within one year 42/48 €262,547 €293,700 +€31,152 +11.9%
Trade debts 44 €55,791 €44,982 -€10,810 -19.4%
Suppliers 440/4 €55,791 €44,982 -€10,810 -19.4%
Taxes, remuneration and social security 45 €18,726 €16,039 -€2,688 -14.4%
Taxes 450/3 €18,726 €16,039 -€2,688 -14.4%
Other amounts payable 47/48 €188,029 €232,679 +€44,650 +23.7%
Accrued charges and deferred income 492/3 €7,803 €7,782 -€21 -0.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €23,577 €23,322 -€255 -1.1%
Other operating charges 640/8 €3,418 €3,515 +€97 +2.8%
Gross operating margin 9900 €215,577 €205,605 -€9,972 -4.6%
Operating profit (loss) 9901 €188,582 €178,768 -€9,815 -5.2%
Financial income 75/76B €1,601 €2,373 +€772 +48.2%
Recurring financial income 75 €1,601 €2,373 +€772 +48.2%
Financial charges 65/66B €18,878 €22,090 +€3,212 +17.0%
Recurring financial charges 65 €18,878 €22,090 +€3,212 +17.0%
Profit (loss) for the period before taxes 9903 €171,306 €159,051 -€12,255 -7.2%
Income taxes 67/77 €50,834 €46,858 -€3,975 -7.8%
Profit (loss) for the period 9904 €120,472 €112,192 -€8,280 -6.9%
Profit (loss) for the period to be appropriated 9905 €120,472 €112,192 -€8,280 -6.9%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.